INVEST IN MAXWELLIA
Maxwellia is backed by Robert Wilson (Chair), Catapult Ventures/GM&C Life Sciences Fund , BioCity and EIS Investors .
We are shortly to announce a £2.5m funding raise in return for 27.5% equity.
If you would like to receive our investment publications please emailing Anna Maxwell our CEO at
2020 Share Offer - coming soon
EIS Tax Breaks
The Enterprise Investment Scheme (EIS) offers generous tax incentives to invest in start-up companies like Maxwellia.
Download our briefing note on the EIS scheme to find out more.